Bydureon (exenatide): Bydureon has an extended-release formulation, requiring just one weekly injection
Sibutramine, a drug no longer available on the market, was an effective weight-loss drug with metabolism-boosting effects and also acted as an appetite suppressant
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
Most patients tolerate treatment very well
This article covers what the research supports, how injections compare to IV infusions, what patients typically experience, and how compounded glutathione is prepared for the patients who receive it
The human IGF-1 literature primarily involves mecasermin (native recombinant IGF-1, brand Increlex), approved for growth failure in children with severe IGF-1 deficiency